Jump to content

Gene Editing Patent Application Trends 2025: Difference between revisions

From WikiPatents
Updating Gene Editing Patent Application Trends 2025
 
Updating Gene Editing Patent Application Trends 2025
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
== Gene Editing Patent Application Filing Activity ==
== Gene Editing Patent Application Filing Activity ==
== Gene Editing patent applications in 2025 ==
== Gene Editing patent applications in 2025 ==
[[File:Gene_Editing_Monthly_Patent_Applications_2025_-_Up_to_February 2025.png|border|800px]]
[[File:Gene_Editing_Monthly_Patent_Applications_2025_-_Up_to_May 2025.png|border|800px]]


== Top Technology Areas in Gene Editing ==
== Top Technology Areas in Gene Editing ==
[[File:Top_Technology_Areas_in_Gene_Editing_2025_-_Up_to_February 2025.png|border|800px]]
[[File:Top_Technology_Areas_in_Gene_Editing_2025_-_Up_to_May 2025.png|border|800px]]


=== Top CPC Codes ===
=== Top CPC Codes ===
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
* [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 79 patents
** Count: 194 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)]]
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 72 patents
** Count: 184 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)]]
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
* [[:Category:CPC_C12N15/11|C12N15/11]] (DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology,)
** Count: 43 patents
** Count: 106 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250115875. COMPOSITIONS AND METHODS FOR CELL ENGINEERING FOR MEAT PRODUCTION (Fork & Goode, Inc.)]]
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
* [[:Category:CPC_C12N15/86|C12N15/86]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 41 patents
** Count: 96 patents
** Example: [[20250034558. COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES (Artisan Development Labs, Inc.)]]
** Example: [[20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)]]
* [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available)
* [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 38 patents
** Count: 85 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)]]
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
* [[:Category:CPC_C12N15/907|C12N15/907]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 30 patents
** Count: 73 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)]]
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
* [[:Category:CPC_C12N15/111|C12N15/111]] ({General methods applicable to biologically active non-coding nucleic acids})
** Count: 30 patents
** Count: 65 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)]]
* [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available)
* [[:Category:CPC_A61K48/0058|A61K48/0058]] (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy)
** Count: 16 patents
** Count: 39 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)]]
* [[:Category:CPC_C12N2800/80|C12N2800/80]] (No explanation available)
* [[:Category:CPC_A61K48/005|A61K48/005]] (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy)
** Count: 13 patents
** Count: 36 patents
** Example: [[20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)]]
** Example: [[20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)]]
* [[:Category:CPC_A61K48/0058|A61K48/0058]] (No explanation available)
* [[:Category:CPC_C12N15/113|C12N15/113]] (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing  (when used in plants)
** Count: 13 patents
** Count: 35 patents
** Example: [[20250064978. GENE THERAPY METHODS FOR TREATMENT OF DIABETES (Jaguar Gene Therapy, LLC)]]
** Example: [[20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)]]


== Top Companies in Gene Editing 2025 ==
== Top Companies in Gene Editing 2025 ==
Line 42: Line 42:


=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 14
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C07K16/2809|C07K16/2809]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 10 patents
** [[:Category:CPC_A61K39/3955|A61K39/3955]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 10 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology,): 6 patents
* Recent patents:
* Recent patents:
** [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] (20250130)
** [[20250145959. COMPOSITIONS AND METHODS FOR PRODUCING SMOOTH MUSCLE CELLS (The Regents of the University of California)]] (20250508)
** [[20250000945. Suppression of Neurodegeneration with Zinc Transporter Protein 7 (The Regents of the University of California)]] (20250102)
** [[20250145968. GENETIC ENGINEERING OF BACTERIOPHAGES USING CRISPR-CAS13A (The Regents of the University of California)]] (20250508)
** [[20250049960. Multicomponent systems for site-specific genome modifications (The Regents of the University of California)]] (20250213)
** [[20250101385. GENE EDITING TO IMPROVE PANCREATIC BETA CELL YIELD IN DIRECTED DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS (The Regents of the University of California)]] (20250327)
=== [[:Category:EmendoBio Inc.|EmendoBio Inc.]] ===
=== [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 13
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_G02B1/002|G02B1/002]] (Optical elements characterised by the material of which they are made; Optical coatings for optical elements): 6 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 3 patents
** [[:Category:CPC_G02B2207/101|G02B2207/101]] (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS): 5 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_G02B13/0055|G02B13/0055]] ({employing a special optical element}): 4 patents
* Recent patents:
* Recent patents:
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]] ===
=== [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 6
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available): 2 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available): 2 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N2830/48|C12N2830/48]] (No explanation available): 2 patents
** [[:Category:CPC_C12N15/907|C12N15/907]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
* Recent patents:
* Recent patents:
** [[20250041445. GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA (The Trustees of the University of Pennsylvania)]] (20250206)
** [[20250171756. NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS (THE BROAD INSTITUTE, INC.)]] (20250529)
** [[20250027900. pH Sensing Technique Based On Graphene Electrodes (The Trustees of the University of Pennsylvania)]] (20250123)
** [[20250171811. TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS (THE BROAD INSTITUTE, INC.)]] (20250529)
** [[20250049949. GENE THERAPY FOR LAMIN A-ASSOCIATED DEFICIENCIES (The Trustees of the University of Pennsylvania)]] (20250213)
** [[20250099623. COMPOSITIONS AND METHODS FOR ENHANCING INTRA-MITOCHONDRIAL PROTEIN TRANSLATION AND OXIDATIVE PHOSPHORYLATION (THE BROAD INSTITUTE, INC.)]] (20250327)
=== [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]] ===
=== [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 6
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_A61P3/00|A61P3/00]] (No explanation available): 2 patents
** [[:Category:CPC_C12N15/8213|C12N15/8213]] ({Targeted insertion of genes into the plant genome by homologous recombination}): 3 patents
* Recent patents:
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250122513. GENERATION OF SITE SPECIFIC INTEGRATION SITES FOR COMPLEX TRAIT LOCI IN CORN AND SOYBEAN, AND METHODS OF USE (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250417)
** [[20250027087. MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE (CRISPR Therapeutics AG)]] (20250123)
** [[20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250417)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
=== [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]] ===
=== [[:Category:The Trustees of Columbia University in the City of New York|The Trustees of Columbia University in the City of New York]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 5
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_G01S7/4816|G01S7/4816]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
** [[:Category:CPC_G02B13/0055|G02B13/0055]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology,): 3 patents
** [[:Category:CPC_G02B13/008|G02B13/008]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
* Recent patents:
* Recent patents:
** [[20250044420. LENS FOR ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250206)
** [[20250171810. COMPOSITIONS, SYSTEMS, AND METHODS FOR PRIME EDITING (The Trustees of Columbia University in the City of New York)]] (20250529)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250163410. CRISPR-TRANSPOSON SYSTEMS FOR DNA MODIFICATION (The Trustees of Columbia University in the City of New York)]] (20250522)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250098652. Genetic Modifications for Xenotransplantation (The Trustees of Columbia University in the City of New York)]] (20250327)
=== [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]] ===
=== [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 5
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 2 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available): 2 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology,): 5 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 2 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
* Recent patents:
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
** [[20250002946. Methods And Compositions For Increasing Homology-Directed Repair (Regeneron Pharmaceuticals, Inc.)]] (20250102)
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
=== [[:Category:Monsanto Technology LLC|Monsanto Technology LLC]] ===
** [[20250154503. COMPOSITIONS, SYSTEMS, AND METHODS FOR PROGRAMMING T CELL PHENOTYPES THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250515)
* Number of Gene Editing patents: 2
=== [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]] ===
* Number of Gene Editing patents: 5
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N15/8213|C12N15/8213]] (No explanation available): 2 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/111|C12N15/111]] ({General methods applicable to biologically active non-coding nucleic acids}): 3 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
* Recent patents:
* Recent patents:
** [[20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)]] (20250130)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
** [[20250027098. METHOD FOR SELECTING TARGET SITES FOR SITE-SPECIFIC GENOME MODIFICATION IN PLANTS (Monsanto Technology LLC)]] (20250123)
** [[20250101468. DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]] ===
** [[20250101500. AMPLIFICATION ASSAYS USING CRISPR-CAS BASED DETECTION (The Broad Institute, Inc.)]] (20250327)
* Number of Gene Editing patents: 2
=== [[:Category:CRISPR THERAPEUTICS AG|CRISPR THERAPEUTICS AG]] ===
* Number of Gene Editing patents: 5
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12Q1/6823|C12Q1/6823]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 5 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 4 patents
** [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available): 1 patents
** [[:Category:CPC_A61K9/5123|A61K9/5123]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 3 patents
* Recent patents:
* Recent patents:
** [[20250034622. SMALL NOVEL CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF (THE BROAD INSTITUTE, INC.)]] (20250130)
** [[20250145998. COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING TRANSFERRIN (CRISPR THERAPEUTICS AG)]] (20250508)
** [[20250043366. TILED ASSAYS USING CRISPR-CAS BASED DETECTION (THE BROAD INSTITUTE, INC.)]] (20250206)
** [[20250011771. METHODS AND COMPOSITIONS FOR TREATING LIPOPROTEIN-RELATED DISEASES (CRISPR THERAPEUTICS AG)]] (20250109)
=== [[:Category:Caribou Biosciences, Inc.|Caribou Biosciences, Inc.]] ===
** [[20250101439. MATERIALS AND METHODS FOR CONTROLLING GENE EDITING (CRISPR THERAPEUTICS AG)]] (20250327)
* Number of Gene Editing patents: 2
=== [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]] ===
* Number of Gene Editing patents: 4
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12Q1/6855|C12Q1/6855]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/86|C12N15/86]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media): 3 patents
** [[:Category:CPC_C07K16/2878|C07K16/2878]] (No explanation available): 1 patents
** [[:Category:CPC_A61K48/0075|A61K48/0075]] (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 2 patents
* Recent patents:
* Recent patents:
** [[20250034633. A METHOD OF CAPTURING CRISPR ENDONUCLEASE CLEAVAGE PRODUCTS (Caribou Biosciences, Inc.)]] (20250130)
** [[20250161493. COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY (The Trustees of the University of Pennsylvania)]] (20250522)
** [[20250027078. DNA-CONTAINING POLYNUCLEOTIDES AND GUIDES FOR CRISPR TYPE V SYSTEMS, AND METHODS OF MAKING AND USING THE SAME (Caribou Biosciences, Inc.)]] (20250123)
** [[20250027900. pH Sensing Technique Based On Graphene Electrodes (The Trustees of the University of Pennsylvania)]] (20250123)
=== [[:Category:UCL BUSINESS LTD|UCL BUSINESS LTD]] ===
** [[20250049949. GENE THERAPY FOR LAMIN A-ASSOCIATED DEFICIENCIES (The Trustees of the University of Pennsylvania)]] (20250213)
* Number of Gene Editing patents: 2
=== [[:Category:Illumina, Inc.|Illumina, Inc.]] ===
* Number of Gene Editing patents: 4
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available): 2 patents
** [[:Category:CPC_G06T7/0014|G06T7/0014]] ({using an image reference approach}): 2 patents
** [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available): 2 patents
** [[:Category:CPC_G06T7/0012|G06T7/0012]] ({Biomedical image inspection}): 2 patents
** [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available): 1 patents
** [[:Category:CPC_G06T7/246|G06T7/246]] (using feature-based methods, e.g. the tracking of corners or segments): 2 patents
* Recent patents:
* Recent patents:
** [[20250064974. ENDOGENOUS GENE REGULATION TO TREAT NEUROLOGICAL DISORDERS AND DISEASES (UCL BUSINESS LTD)]] (20250227)
** [[20250166733. DETERMINING STRUCTURAL VARIANTS (Illumina, Inc.)]] (20250522)
** [[20250057899. GENE THERAPY FOR CILIOPATHIES (UCL BUSINESS LTD)]] (20250220)
** [[20250148603. CREATING A TEMPLATE OF NUCLEIC ACID SITE LOCATIONS ON A FLOW CELL (Illumina, Inc.)]] (20250508)
** [[20250148604. ANALYZING IMAGE DATA FROM NUCLEIC ACID SEQUENCING (Illumina, Inc.)]] (20250508)


== New Companies in Gene Editing (Last Month) ==
== New Companies in Gene Editing (Last Month) ==
Line 145: Line 150:
[[File:Emerging_Technology_Areas_in_Gene_Editing.png|border|800px]]
[[File:Emerging_Technology_Areas_in_Gene_Editing.png|border|800px]]


* [[:Category:CPC_G06T2207/20212|G06T2207/20212]] (No explanation available)
* [[:Category:CPC_C12Y302/0101|C12Y302/0101]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G06T2207/10024|G06T2207/10024]] (No explanation available)
* [[:Category:CPC_C12Y301/03024|C12Y301/03024]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_H04N23/16|H04N23/16]] (No explanation available)
* [[:Category:CPC_C12Y301/0301|C12Y301/0301]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G06T7/80|G06T7/80]] (No explanation available)
* [[:Category:CPC_C12Y301/03009|C12Y301/03009]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G06T5/80|G06T5/80]] (No explanation available)
* [[:Category:CPC_C12Y207/07027|C12Y207/07027]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G06T5/50|G06T5/50]] (No explanation available)
* [[:Category:CPC_C12Y207/07009|C12Y207/07009]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_G02B27/141|G02B27/141]] (No explanation available)
* [[:Category:CPC_C12Y207/01002|C12Y207/01002]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_H04N9/646|H04N9/646]] (No explanation available)
* [[:Category:CPC_C12Y207/01001|C12Y207/01001]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250016295. CAMERA MODULE WITH CHROMATIC ABERRATION CORRECTION (Meta Platforms Technologies, LLC)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_B82Y30/00|B82Y30/00]] (No explanation available)
* [[:Category:CPC_C12Y204/01014|C12Y204/01014]] (ENZYMES)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250015474. METALENS (FUJIFILM Corporation)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]
* [[:Category:CPC_H01P3/20|H01P3/20]] (No explanation available)
* [[:Category:CPC_C12P19/12|C12P19/12]] (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250015474. METALENS (FUJIFILM Corporation)]]
** Example: [[20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)]]


== Top Companies in Emerging Gene Editing Technologies 2025==
== Top Companies in Emerging Gene Editing Technologies 2025==
[[File:Top_Companies_in_Emerging_Gene_Editing_Technologies.png|border|800px]]
[[File:Top_Companies_in_Emerging_Gene_Editing_Technologies.png|border|800px]]


* [[:Category:Meta Platforms Technologies, LLC|Meta Platforms Technologies, LLC]]: 8 patents
* [[:Category:SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY|SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY]]: 10 patents
* [[:Category:FUJIFILM Corporation|FUJIFILM Corporation]]: 2 patents


== Top Inventors in Gene Editing ==
== Top Inventors in Gene Editing ==
Line 186: Line 190:


=== [[:Category:Chenglong HAO|Chenglong HAO]] ===
=== [[:Category:Chenglong HAO|Chenglong HAO]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 13
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 13 patents
* Recent patents:
* Recent patents:
** [[20250044420. LENS FOR ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250206)
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Fengze TAN|Fengze TAN]] ===
=== [[:Category:Fengze TAN|Fengze TAN]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 13
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 13 patents
* Recent patents:
* Recent patents:
** [[20250044420. LENS FOR ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250206)
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Jian ZHU|Jian ZHU]] ===
=== [[:Category:Jian ZHU|Jian ZHU]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 13
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 13 patents
* Recent patents:
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Feng Zhang|Feng Zhang of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 5
* Top companies:
** [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]]: 4 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 1 patents
* Recent patents:
** [[20250171756. NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS (THE BROAD INSTITUTE, INC.)]] (20250529)
** [[20250171811. TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS (THE BROAD INSTITUTE, INC.)]] (20250529)
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
=== [[:Category:JOSHUA K. YOUNG|JOSHUA K. YOUNG of JOHNSTON IA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
** [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]]: 4 patents
* Recent patents:
* Recent patents:
** [[20250044420. LENS FOR ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250206)
** [[20250163393. METHODS AND COMPOSITIONS FOR ADVANCED BREEDING THROUGH TARGETED CHROMOSOME ENGINEERING (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250522)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250417)
=== [[:Category:Leida Rassouli-Taylor|Leida Rassouli-Taylor of Philadelphia PA (US)]] ===
=== [[:Category:Chris RAMSBORG|Chris RAMSBORG of Seattle WA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 4
* Top companies:
* Top companies:
** [[:Category:Amicus Therapeutics, Inc|Amicus Therapeutics, Inc]]: 1 patents
** [[:Category:Juno Therapeutics, Inc.|Juno Therapeutics, Inc.]]: 4 patents
** [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250034533. Compositions And Methods For Treating Mucopolysaccharidosis IIIA (Amicus Therapeutics, Inc)]] (20250130)
** [[20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250522)
** [[20250041445. GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA (The Trustees of the University of Pennsylvania)]] (20250206)
** [[20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250515)
=== [[:Category:Lior IZHAR|Lior IZHAR]] ===
** [[20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250417)
* Number of Gene Editing patents: 2
=== [[:Category:Mark L. BONYHADI|Mark L. BONYHADI of Sammamish WA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 1 patents
** [[:Category:Juno Therapeutics, Inc.|Juno Therapeutics, Inc.]]: 4 patents
** [[:Category:EMENDOBIO INC|EMENDOBIO INC]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250522)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
** [[20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250515)
=== [[:Category:Liat ROCKAH|Liat ROCKAH]] ===
** [[20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250417)
* Number of Gene Editing patents: 2
=== [[:Category:Calvin CHAN|Calvin CHAN of Seattle WA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 1 patents
** [[:Category:Juno Therapeutics, Inc.|Juno Therapeutics, Inc.]]: 4 patents
** [[:Category:EMENDOBIO INC|EMENDOBIO INC]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250522)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
** [[20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250515)
=== [[:Category:Nir HECHT|Nir HECHT]] ===
** [[20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250417)
* Number of Gene Editing patents: 2
=== [[:Category:Pascal BEAUCHESNE|Pascal BEAUCHESNE of Seattle WA (US)]] ===
* Number of Gene Editing patents: 4
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 1 patents
** [[:Category:Juno Therapeutics, Inc.|Juno Therapeutics, Inc.]]: 4 patents
** [[:Category:EMENDOBIO INC|EMENDOBIO INC]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250522)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
** [[20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250515)
** [[20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.)]] (20250417)
=== [[:Category:Alexandra Briner Crawley|Alexandra Briner Crawley of Cary NC (US)]] ===
=== [[:Category:Alexandra Briner Crawley|Alexandra Briner Crawley of Cary NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 2 patents
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 2 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Tedd D. Elich|Tedd D. Elich of Durham NC (US)]] ===
=== [[:Category:Tedd D. Elich|Tedd D. Elich of Durham NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 2 patents
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 2 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
=== [[:Category:Eric B. Kmiec|Eric B. Kmiec of Middletown DE (US)]] ===
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
* Number of Gene Editing patents: 2
=== [[:Category:Brian COSGROVE|Brian COSGROVE of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Christiana Care Gene Editing Institute, Inc.|Christiana Care Gene Editing Institute, Inc.]]: 2 patents
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250001010. NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER (Christiana Care Gene Editing Institute, Inc.)]] (20250102)
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250018060. ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT (Christiana Care Gene Editing Institute, Inc.)]] (20250116)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
=== [[:Category:Kelly H. Banas|Kelly H. Banas of Bear DE (US)]] ===
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
* Number of Gene Editing patents: 2
=== [[:Category:Kendra CONGDON|Kendra CONGDON of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Christiana Care Gene Editing Institute, Inc.|Christiana Care Gene Editing Institute, Inc.]]: 2 patents
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250001010. NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER (Christiana Care Gene Editing Institute, Inc.)]] (20250102)
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250018060. ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT (Christiana Care Gene Editing Institute, Inc.)]] (20250116)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
=== [[:Category:Joseph J. HIGGINS|Joseph J. HIGGINS of Lexington MA (US)]] ===
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
* Number of Gene Editing patents: 2
=== [[:Category:Jason DEAN|Jason DEAN of Seattle WA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Saliogen Therapeutics, Inc.|Saliogen Therapeutics, Inc.]]: 2 patents
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250002876. MOBILE ELEMENTS AND CHIMERIC CONSTRUCTS THEREOF (Saliogen Therapeutics, Inc.)]] (20250102)
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250011736. TRANSPOSABLE MOBILE ELEMENTS WITH ENHANCED GENOMIC SITE SELECTION (Saliogen Therapeutics, Inc.)]] (20250109)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
=== [[:Category:Nancy CRAIG|Nancy CRAIG of Lexington MA (US)]] ===
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
* Number of Gene Editing patents: 2
=== [[:Category:Veronica GOUGH|Veronica GOUGH of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Saliogen Therapeutics, Inc.|Saliogen Therapeutics, Inc.]]: 2 patents
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250002876. MOBILE ELEMENTS AND CHIMERIC CONSTRUCTS THEREOF (Saliogen Therapeutics, Inc.)]] (20250102)
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250011736. TRANSPOSABLE MOBILE ELEMENTS WITH ENHANCED GENOMIC SITE SELECTION (Saliogen Therapeutics, Inc.)]] (20250109)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
=== [[:Category:Christopher BROWN|Christopher BROWN of Albany CA (US)]] ===
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
* Number of Gene Editing patents: 2
=== [[:Category:Joshua B. BLACK|Joshua B. BLACK of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Metagenomi, Inc.|Metagenomi, Inc.]]: 1 patents
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
** [[:Category:METAGENOMI, INC.|METAGENOMI, INC.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.)]] (20250102)
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.)]] (20250220)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
=== [[:Category:Cindy CASTELLE|Cindy CASTELLE of San Francisco CA (US)]] ===
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
* Number of Gene Editing patents: 2
=== [[:Category:Britta JONES|Britta JONES of Durham NC (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Metagenomi, Inc.|Metagenomi, Inc.]]: 1 patents
** [[:Category:Tune Therapeutics, Inc.|Tune Therapeutics, Inc.]]: 3 patents
** [[:Category:METAGENOMI, INC.|METAGENOMI, INC.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.)]] (20250102)
** [[20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250424)
** [[20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.)]] (20250220)
** [[20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250501)
=== [[:Category:Lisa ALEXANDER|Lisa ALEXANDER of Albany CA (US)]] ===
** [[20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.)]] (20250529)
* Number of Gene Editing patents: 2
=== [[:Category:Heshan LIN|Heshan LIN]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Metagenomi, Inc.|Metagenomi, Inc.]]: 1 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
** [[:Category:METAGENOMI, INC.|METAGENOMI, INC.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.)]] (20250102)
** [[20250130399. OPTICAL SYSTEM AND OPTICAL CAMERA (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250424)
** [[20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.)]] (20250220)
** [[20250138162. OPTICAL SYSTEM FOR ToF AND DEPTH CAMERA OF ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250501)
=== [[:Category:Yi-Shan Chen|Yi-Shan Chen of South Boston MA (US)]] ===
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
* Number of Gene Editing patents: 2
=== [[:Category:ZHENGLIN HOU|ZHENGLIN HOU of ANKENY IA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
** [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250417)
=== [[:Category:Sandeep Soni|Sandeep Soni of South Boston CA (US)]] ===
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
* Number of Gene Editing patents: 2
=== [[:Category:Jonathan Gootenberg|Jonathan Gootenberg of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
** [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]]: 1 patents
** [[:Category:Massachusetts Institute of Technology|Massachusetts Institute of Technology]]: 1 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250092390. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) (Massachusetts Institute of Technology)]] (20250320)
=== [[:Category:Laura Serwer|Laura Serwer of South Boston MA (US)]] ===
** [[20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.)]] (20250327)
* Number of Gene Editing patents: 2
=== [[:Category:Shengkan Jin|Shengkan Jin of Belle Mead NJ (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
** [[:Category:Rutgers, The State University of New Jersey|Rutgers, The State University of New Jersey]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250171808. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey)]] (20250529)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250163473. TARGETED GENE EDITING PLATFORM INDEPENDENT OF DNA DOUBLE STRAND BREAK AND USES THEREOF (Rutgers, The State University of New Jersey)]] (20250522)
=== [[:Category:Jonathan Terrett|Jonathan Terrett of South Boston MA (US)]] ===
** [[20250101464. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey)]] (20250327)
* Number of Gene Editing patents: 2
=== [[:Category:Juan-Carlos Collantes|Juan-Carlos Collantes of Princeton NJ (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
** [[:Category:Rutgers, The State University of New Jersey|Rutgers, The State University of New Jersey]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250171808. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey)]] (20250529)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250163473. TARGETED GENE EDITING PLATFORM INDEPENDENT OF DNA DOUBLE STRAND BREAK AND USES THEREOF (Rutgers, The State University of New Jersey)]] (20250522)
=== [[:Category:John Kulman|John Kulman of South Boston MA (US)]] ===
** [[20250101464. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey)]] (20250327)
* Number of Gene Editing patents: 2
=== [[:Category:David R. Liu|David R. Liu of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 2 patents
** [[:Category:President and Fellows of Harvard College|President and Fellows of Harvard College]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250043261. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250206)
** [[20250090687. MITOCHONDRIAL BASE EDITORS AND METHODS FOR EDITING MITOCHONDRIAL DNA (The Broad Institute, Inc.)]] (20250320)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250092374. EVOLVED CAS9 PROTEINS FOR GENE EDITING (President and Fellows of Harvard College)]] (20250320)
=== [[:Category:Benjamin OAKES|Benjamin OAKES of El Cerrito CA (US)]] ===
** [[20250011748. BASE EDITORS, COMPOSITIONS, AND METHODS FOR MODIFYING THE MITOCHONDRIAL GENOME (The Broad Institute, Inc.)]] (20250109)
* Number of Gene Editing patents: 2
=== [[:Category:William Douglass WRIGHT|William Douglass WRIGHT of Fairfield CA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
** [[:Category:Mammoth Biosciences, Inc.|Mammoth Biosciences, Inc.]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250154505. EFFECTOR PROTEINS AND METHODS OF USE (Mammoth Biosciences, Inc.)]] (20250515)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
** [[20250145974. ENGINEERED CAS-PHI PROTEINS AND USES THEREOF (Mammoth Biosciences, Inc.)]] (20250508)
=== [[:Category:Sean HIGGINS|Sean HIGGINS of Alameda CA (US)]] ===
** [[20250101498. EFFECTOR PROTEINS, COMPOSITIONS, SYSTEMS, DEVICES, KITS AND METHODS OF USE THEREOF (Mammoth Biosciences, Inc.)]] (20250327)
* Number of Gene Editing patents: 2
=== [[:Category:Lucas Benjamin HARRINGTON|Lucas Benjamin HARRINGTON of San Francisco CA (US)]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
** [[:Category:Mammoth Biosciences, Inc.|Mammoth Biosciences, Inc.]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250154505. EFFECTOR PROTEINS AND METHODS OF USE (Mammoth Biosciences, Inc.)]] (20250515)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
** [[20250144246. COMPOSITIONS AND METHODS FOR MODIFYING A HUMAN DYSTROPHIN GENE (Mammoth Biosciences, Inc.)]] (20250508)
=== [[:Category:Sarah DENNY|Sarah DENNY of San Francisco CA (US)]] ===
** [[20250145974. ENGINEERED CAS-PHI PROTEINS AND USES THEREOF (Mammoth Biosciences, Inc.)]] (20250508)
* Number of Gene Editing patents: 2
=== [[:Category:Rui ZHU|Rui ZHU]] ===
* Number of Gene Editing patents: 3
* Top companies:
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
* Recent patents:
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
** [[20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Brett T. STAAHL|Brett T. STAAHL of Tiburon CA (US)]] ===
** [[20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250417)
=== [[:Category:Clayton BEARD|Clayton BEARD of Durham NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
** [[:Category:BridgeBio Gene Therapy Research, Inc.|BridgeBio Gene Therapy Research, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)]] (20250410)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
** [[20250001008. GENE THERAPY FOR GALACTOSEMIA (BridgeBio Gene Therapy Research, Inc.)]] (20250102)
=== [[:Category:Isabel COLIN|Isabel COLIN of Oakland CA (US)]] ===
=== [[:Category:Charles A. Gersbach|Charles A. Gersbach of Chapel Hill NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Scribe Therapeutics Inc.|Scribe Therapeutics Inc.]]: 2 patents
** [[:Category:Duke University|Duke University]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250043262. GENE EDITING PAIRS (Scribe Therapeutics Inc.)]] (20250206)
** [[20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)]] (20250410)
** [[20250011756. METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS (Scribe Therapeutics Inc.)]] (20250109)
** [[20250171754. CRISPR-CAS9 COMPOSITIONS AND METHODS WITH A NOVEL CAS9 PROTEIN FOR GENOME EDITING AND GENE REGULATION (Duke University)]] (20250529)
=== [[:Category:Edwin Neumann|Edwin Neumann of Somerville MA (US)]] ===
=== [[:Category:Tzu-Yao Lin|Tzu-Yao Lin]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Whitehead Institute for Biomedical Research|Whitehead Institute for Biomedical Research]]: 2 patents
** [[:Category:GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED|GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250019673. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250116)
** [[20250116761. OPTICAL DEPTH SENSING APPARATUS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED)]] (20250410)
** [[20250027059. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250123)
** [[20250164758. IMAGING LENS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED)]] (20250522)
=== [[:Category:Tessa Bertozzi|Tessa Bertozzi of Cambridge MA (US)]] ===
=== [[:Category:Shih-Chieh Yen|Shih-Chieh Yen]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Whitehead Institute for Biomedical Research|Whitehead Institute for Biomedical Research]]: 2 patents
** [[:Category:GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED|GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250019673. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250116)
** [[20250116761. OPTICAL DEPTH SENSING APPARATUS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED)]] (20250410)
** [[20250027059. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250123)
** [[20250164758. IMAGING LENS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED)]] (20250522)
=== [[:Category:Jonathan Weissman|Jonathan Weissman of Cambridge MA (US)]] ===
=== [[:Category:Leida Rassouli-Taylor|Leida Rassouli-Taylor of Philadelphia PA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Whitehead Institute for Biomedical Research|Whitehead Institute for Biomedical Research]]: 2 patents
** [[:Category:Amicus Therapeutics, Inc|Amicus Therapeutics, Inc]]: 1 patents
** [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250019673. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250116)
** [[20250034533. Compositions And Methods For Treating Mucopolysaccharidosis IIIA (Amicus Therapeutics, Inc)]] (20250130)
** [[20250027059. Compositions and Methods for Making Epigenetic Modifications (Whitehead Institute for Biomedical Research)]] (20250123)
** [[20250041445. GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA (The Trustees of the University of Pennsylvania)]] (20250206)
=== [[:Category:Jesse Salk|Jesse Salk of Seattle WA (US)]] ===
=== [[:Category:Lior IZHAR|Lior IZHAR]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION|UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION]]: 2 patents
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 1 patents
** [[:Category:EMENDOBIO INC|EMENDOBIO INC]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250019761. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250116)
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250011866. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250109)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
=== [[:Category:Lawrence A. Loeb|Lawrence A. Loeb of Bellevue WA (US)]] ===
=== [[:Category:Liat ROCKAH|Liat ROCKAH]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION|UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION]]: 2 patents
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 1 patents
** [[:Category:EMENDOBIO INC|EMENDOBIO INC]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250019761. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250116)
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250011866. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250109)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
=== [[:Category:Michael Schmitt|Michael Schmitt of Seattle WA (US)]] ===
=== [[:Category:Nir HECHT|Nir HECHT]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION|UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION]]: 2 patents
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 1 patents
** [[:Category:EMENDOBIO INC|EMENDOBIO INC]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250019761. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250116)
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250011866. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250109)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
=== [[:Category:Lior Izhar|Lior Izhar]] ===
=== [[:Category:Tyson D. Bowen|Tyson D. Bowen of Morrisville NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 1 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Nadav Marbach Bar|Nadav Marbach Bar]] ===
=== [[:Category:Mark Moore|Mark Moore of Durham NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 1 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Liat Rockah|Liat Rockah]] ===
=== [[:Category:Michael Lassner|Michael Lassner of Portland OR (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:LifeEDIT Therapeutics, Inc.|LifeEDIT Therapeutics, Inc.]]: 1 patents
** [[:Category:Life Edit Therapeutics, Inc.|Life Edit Therapeutics, Inc.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.)]] (20250320)
=== [[:Category:Nurit Meron|Nurit Meron]] ===
=== [[:Category:Andrew Garst|Andrew Garst of Pleasanton CA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:Inscripta, Inc.|Inscripta, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250227)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250306)
=== [[:Category:Ophir Adiv Tal|Ophir Adiv Tal]] ===
=== [[:Category:Ryan T. Gill|Ryan T. Gill of Pleasanton CA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:Inscripta, Inc.|Inscripta, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250227)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250306)
=== [[:Category:Ariel Gispan|Ariel Gispan]] ===
=== [[:Category:Tanya Elizabeth Warnecke Lipscomb|Tanya Elizabeth Warnecke Lipscomb of Pleasanton CA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:Inscripta, Inc.|Inscripta, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250227)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250306)
=== [[:Category:Idit Buch|Idit Buch]] ===
=== [[:Category:Cameron Myhrvold|Cameron Myhrvold of Princeton NJ (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
** [[:Category:MASSACHUSETTS INSTITUTE OF TECHNOLOGY|MASSACHUSETTS INSTITUTE OF TECHNOLOGY]]: 1 patents
** [[:Category:The Trustees of Princeton University|The Trustees of Princeton University]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250066842. SPLIT-LUCIFERASE REPORTER SYSTEMS, COLOR-CODED BEAD MULTIPLEX CRISPR SYSTEMS, AND METHODS OF USE THEREOF IN CRISPR-CAS BASED DIAGNOSTICS (MASSACHUSETTS INSTITUTE OF TECHNOLOGY)]] (20250227)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250146089. ABERRANT VIRAL RNA DETECTION USING CAS13 (The Trustees of Princeton University)]] (20250508)
=== [[:Category:Abdoulaye Ndao|Abdoulaye Ndao of Brookline MA (US)]] ===
=== [[:Category:Eric B. Kmiec|Eric B. Kmiec of Middletown DE (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Imagia, Inc.|Imagia, Inc.]]: 2 patents
** [[:Category:Christiana Care Gene Editing Institute, Inc.|Christiana Care Gene Editing Institute, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250052925. Frequency-Selective Optical Metalens Filters (Imagia, Inc.)]] (20250213)
** [[20250001010. NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER (Christiana Care Gene Editing Institute, Inc.)]] (20250102)
** [[20250012944. Optical Metalens Systems and Methods of Manufacture (Imagia, Inc.)]] (20250109)
** [[20250018060. ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT (Christiana Care Gene Editing Institute, Inc.)]] (20250116)
=== [[:Category:Dan Michael WEINTHAL|Dan Michael WEINTHAL]] ===
=== [[:Category:Kelly H. Banas|Kelly H. Banas of Bear DE (US)]] ===
* Number of Gene Editing patents: 1
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Targetgene Biotechnologies Ltd.|Targetgene Biotechnologies Ltd.]]: 1 patents
** [[:Category:Christiana Care Gene Editing Institute, Inc.|Christiana Care Gene Editing Institute, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
** [[20250001010. NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER (Christiana Care Gene Editing Institute, Inc.)]] (20250102)
=== [[:Category:Yoel Moshe SHIBOLETH|Yoel Moshe SHIBOLETH]] ===
** [[20250018060. ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT (Christiana Care Gene Editing Institute, Inc.)]] (20250116)
* Number of Gene Editing patents: 1
=== [[:Category:Joseph J. HIGGINS|Joseph J. HIGGINS of Lexington MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Targetgene Biotechnologies Ltd.|Targetgene Biotechnologies Ltd.]]: 1 patents
** [[:Category:Saliogen Therapeutics, Inc.|Saliogen Therapeutics, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
** [[20250002876. MOBILE ELEMENTS AND CHIMERIC CONSTRUCTS THEREOF (Saliogen Therapeutics, Inc.)]] (20250102)
=== [[:Category:David STEINER|David STEINER]] ===
** [[20250011736. TRANSPOSABLE MOBILE ELEMENTS WITH ENHANCED GENOMIC SITE SELECTION (Saliogen Therapeutics, Inc.)]] (20250109)
* Number of Gene Editing patents: 1
=== [[:Category:Nancy CRAIG|Nancy CRAIG of Lexington MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Targetgene Biotechnologies Ltd.|Targetgene Biotechnologies Ltd.]]: 1 patents
** [[:Category:Saliogen Therapeutics, Inc.|Saliogen Therapeutics, Inc.]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
** [[20250002876. MOBILE ELEMENTS AND CHIMERIC CONSTRUCTS THEREOF (Saliogen Therapeutics, Inc.)]] (20250102)
=== [[:Category:Talya KUNIK|Talya KUNIK]] ===
** [[20250011736. TRANSPOSABLE MOBILE ELEMENTS WITH ENHANCED GENOMIC SITE SELECTION (Saliogen Therapeutics, Inc.)]] (20250109)
* Number of Gene Editing patents: 1
=== [[:Category:Christopher BROWN|Christopher BROWN of Albany CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Targetgene Biotechnologies Ltd.|Targetgene Biotechnologies Ltd.]]: 1 patents
** [[:Category:Metagenomi, Inc.|Metagenomi, Inc.]]: 1 patents
** [[:Category:METAGENOMI, INC.|METAGENOMI, INC.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
** [[20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.)]] (20250102)
=== [[:Category:Khalid SHAH|Khalid SHAH of Andover MA (US)]] ===
** [[20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.)]] (20250220)
* Number of Gene Editing patents: 1
=== [[:Category:Cindy CASTELLE|Cindy CASTELLE of San Francisco CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:THE BRIGHAM AND WOMEN'S HOSPITAL, INC.|THE BRIGHAM AND WOMEN'S HOSPITAL, INC.]]: 1 patents
** [[:Category:Metagenomi, Inc.|Metagenomi, Inc.]]: 1 patents
** [[:Category:METAGENOMI, INC.|METAGENOMI, INC.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250032611. GENE EDITING AND ENGINEERING STEM CELLS FOR DRUG DELIVERY (THE BRIGHAM AND WOMEN'S HOSPITAL, INC.)]] (20250130)
** [[20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.)]] (20250102)
=== [[:Category:Andrew Baik|Andrew Baik of Scarsdale NY (US)]] ===
** [[20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.)]] (20250220)
* Number of Gene Editing patents: 1
=== [[:Category:Lisa ALEXANDER|Lisa ALEXANDER of Albany CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
** [[:Category:Metagenomi, Inc.|Metagenomi, Inc.]]: 1 patents
** [[:Category:METAGENOMI, INC.|METAGENOMI, INC.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
** [[20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.)]] (20250102)
=== [[:Category:Katherine Cygnar|Katherine Cygnar of New York NY (US)]] ===
** [[20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.)]] (20250220)
* Number of Gene Editing patents: 1
=== [[:Category:Tirtha Chakraborty|Tirtha Chakraborty of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
** [[:Category:Vertex Pharmaceuticals Incorporated|Vertex Pharmaceuticals Incorporated]]: 1 patents
** [[:Category:VOR BIOPHARMA INC.|VOR BIOPHARMA INC.]]: 1 patents
* Recent patents:
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
** [[20250041349. CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and Uses Thereof (Vertex Pharmaceuticals Incorporated)]] (20250206)
=== [[:Category:Leah Sabin|Leah Sabin of Goldens Bridge NY (US)]] ===
** [[20250140342. GENOTYPING CELLS USING SINGLE-CELL DNA SEQUENCING DATA (VOR BIOPHARMA INC.)]] (20250501)
* Number of Gene Editing patents: 1
=== [[:Category:James M. Wilson|James M. Wilson of Philadelphia PA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
** [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]]: 2 patents
* Recent patents:
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
** [[20250041445. GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA (The Trustees of the University of Pennsylvania)]] (20250206)
=== [[:Category:Poulami Samai|Poulami Samai of New York NY (US)]] ===
** [[20250161493. COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY (The Trustees of the University of Pennsylvania)]] (20250522)
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
=== [[:Category:Philip Calafati|Philip Calafati of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)


== Top Collaborations in Gene Editing ==
== Top Collaborations in Gene Editing ==
Line 546: Line 594:
[[File:Top_20_Cities_for_Gene_Editing_Inventors.png|border|800px]]
[[File:Top_20_Cities_for_Gene_Editing_Inventors.png|border|800px]]


* Cambridge: 28 inventors
* Cambridge: 92 inventors
* Shanghai: 19 inventors
* Shenzhen: 63 inventors
* San Francisco: 17 inventors
* San Francisco: 48 inventors
* Philadelphia: 17 inventors
* Shanghai: 40 inventors
* South Boston: 17 inventors
* Durham: 36 inventors
* Shenzhen: 13 inventors
* Seattle: 36 inventors
* Pleasanton: 12 inventors
* Philadelphia: 30 inventors
* Qingdao: 12 inventors
* New York: 27 inventors
* New York: 11 inventors
* San Diego: 27 inventors
* Berkeley: 11 inventors
* Pleasanton: 25 inventors
* Oakland: 11 inventors
* Boston: 22 inventors
* Boston: 10 inventors
* La Jolla: 21 inventors
* Rehovot: 9 inventors
* Oakland: 21 inventors
* London: 9 inventors
* South Boston: 21 inventors
* San Diego: 8 inventors
* Suwon-si: 20 inventors
* Beijing: 8 inventors
* London: 19 inventors
* Worcester: 7 inventors
* Wuxi: 16 inventors
* CAMBRIDGE: 7 inventors
* Beijing: 16 inventors
* St. Louis: 7 inventors
* Berkeley: 15 inventors
* Tel Aviv: 7 inventors
* Baltimore: 13 inventors


[[Category:Gene Editing]]
[[Category:Gene Editing]]
[[Category:Patent Application Trends by Technology in 2025]]
[[Category:Patent Application Trends by Technology in 2025]]

Latest revision as of 04:41, 4 June 2025

Gene Editing Patent Application Filing Activity

Gene Editing patent applications in 2025

Top Technology Areas in Gene Editing

Top CPC Codes

Top Companies in Gene Editing 2025

The Regents of the University of California

SHENZHEN METALENX TECHNOLOGY CO.,LTD

THE BROAD INSTITUTE, INC.

PIONEER HI-BRED INTERNATIONAL, INC.

The Trustees of Columbia University in the City of New York

Tune Therapeutics, Inc.

The Broad Institute, Inc.

CRISPR THERAPEUTICS AG

The Trustees of the University of Pennsylvania

Illumina, Inc.

New Companies in Gene Editing (Last Month)

File:New Companies in Gene Editing Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Gene Editing

Top Companies in Emerging Gene Editing Technologies 2025

Top Inventors in Gene Editing

Chenglong HAO

Fengze TAN

Jian ZHU

Feng Zhang of Cambridge MA (US)

JOSHUA K. YOUNG of JOHNSTON IA (US)

Chris RAMSBORG of Seattle WA (US)

Mark L. BONYHADI of Sammamish WA (US)

Calvin CHAN of Seattle WA (US)

Pascal BEAUCHESNE of Seattle WA (US)

Alexandra Briner Crawley of Cary NC (US)

Tedd D. Elich of Durham NC (US)

Brian COSGROVE of Durham NC (US)

Kendra CONGDON of Durham NC (US)

Jason DEAN of Seattle WA (US)

Veronica GOUGH of Durham NC (US)

Joshua B. BLACK of Durham NC (US)

Britta JONES of Durham NC (US)

Heshan LIN

ZHENGLIN HOU of ANKENY IA (US)

Jonathan Gootenberg of Cambridge MA (US)

Shengkan Jin of Belle Mead NJ (US)

Juan-Carlos Collantes of Princeton NJ (US)

David R. Liu of Cambridge MA (US)

William Douglass WRIGHT of Fairfield CA (US)

Lucas Benjamin HARRINGTON of San Francisco CA (US)

Rui ZHU

Clayton BEARD of Durham NC (US)

Charles A. Gersbach of Chapel Hill NC (US)

Tzu-Yao Lin

Shih-Chieh Yen

Leida Rassouli-Taylor of Philadelphia PA (US)

Lior IZHAR

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Liat ROCKAH

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Nir HECHT

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Tyson D. Bowen of Morrisville NC (US)

Mark Moore of Durham NC (US)

Michael Lassner of Portland OR (US)

Andrew Garst of Pleasanton CA (US)

Ryan T. Gill of Pleasanton CA (US)

Tanya Elizabeth Warnecke Lipscomb of Pleasanton CA (US)

Cameron Myhrvold of Princeton NJ (US)

Eric B. Kmiec of Middletown DE (US)

Kelly H. Banas of Bear DE (US)

Joseph J. HIGGINS of Lexington MA (US)

Nancy CRAIG of Lexington MA (US)

Christopher BROWN of Albany CA (US)

Cindy CASTELLE of San Francisco CA (US)

Lisa ALEXANDER of Albany CA (US)

Tirtha Chakraborty of Cambridge MA (US)

James M. Wilson of Philadelphia PA (US)

Top Collaborations in Gene Editing

Top US States for Gene Editing Inventors


Top Cities for Gene Editing Inventors

  • Cambridge: 92 inventors
  • Shenzhen: 63 inventors
  • San Francisco: 48 inventors
  • Shanghai: 40 inventors
  • Durham: 36 inventors
  • Seattle: 36 inventors
  • Philadelphia: 30 inventors
  • New York: 27 inventors
  • San Diego: 27 inventors
  • Pleasanton: 25 inventors
  • Boston: 22 inventors
  • La Jolla: 21 inventors
  • Oakland: 21 inventors
  • South Boston: 21 inventors
  • Suwon-si: 20 inventors
  • London: 19 inventors
  • Wuxi: 16 inventors
  • Beijing: 16 inventors
  • Berkeley: 15 inventors
  • Baltimore: 13 inventors
Retrieved from "https://wikipatents.org/index.php?title=Gene_Editing_Patent_Application_Trends_2025&oldid=614074"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.